Skip to main content
. Author manuscript; available in PMC: 2006 Sep 1.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3188–3196. doi: 10.1167/iovs.05-0321

Figure 2.

Figure 2

Total amacrine cells labeled by both GABA and glycine in the GCL and INL compared with axon loss in glaucomatous eyes. Amacrine cell count compared with the degree of RGC axon loss in rats with glaucoma shows a statistically non-significant trend toward fewer amacrine cells with greater damage (P = 0.11).